Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor.

The OIC-Secretary of Health (SOH) approves the HTA Council recommendation on the non-financing of cerebrolysin in combination with rehabilitation or standard of care for the treatment of adults post-ischemic stroke by the government through its non-inclusion in the Philippine National Formulary, effective as of 25 April 2023.

We shall share the Department of Health’s circular once available.

Evidence Summary: bit.ly/FinalCerebrolysinES

To keep updated on HTA news, visit our website: https://hta.doh.gov.ph/
Like and follow our FB page: bit.ly/HTA-OfficialFB